Tianda Pharmaceuticals Ltd. (HK:0455) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Tianda Pharmaceuticals Ltd. reported lower revenues and a steeper loss for the first half of 2024, with revenue dropping to HK$156,073,000 from HK$303,484,000 in the previous year, and net losses increasing to HK$27,225,000 from HK$4,911,000. The company also experienced a total comprehensive loss of HK$41,924,000, exacerbated by other comprehensive losses related to changes in equity investment values and exchange rate fluctuations.
For further insights into HK:0455 stock, check out TipRanks’ Stock Analysis page.